Skip to main content Accessibility help
×
Home

The damage response framework and infection prevention: From concept to bedside

  • Emily J. Godbout (a1), Theresa Madaline (a2), Arturo Casadevall (a3), Gonzalo Bearman (a4) and Liise-anne Pirofski (a2)...

Abstract

Hospital-acquired infections remain a common cause of morbidity and mortality despite advances in infection prevention through use of bundles, environmental cleaning, antimicrobial stewardship, and other best practices. Current prevention strategies and further hospital-acquired infection reduction are limited by lack of recognition of the role that host–microbe interactions play in susceptibility and by the inability to analyze multiple risk factors in real time to accurately predict the likelihood of a hospital-acquired infection before it occurs and to inform medical decision making. Herein, we examine the value of incorporating the damage-response framework and host attributes that determine susceptibility to infectious diseases known by the acronym MISTEACHING (ie, microbiome, immunity, sex, temperature, environment, age, chance, history, inoculum, nutrition, genetics) into infection prevention strategies using machine learning to drive decision support and patient-specific interventions.

Copyright

Corresponding author

Author for correspondence: Emily J. Godbout, E-mail: emily.godbout@vcuhealth.org

References

Hide All
1.Casadevall, A, Pirofski, LA.Host–pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun 1999;67:37033713.
2.Casadevall, A, Pirofski, LA.The damage–response framework of microbial pathogenesis. Nat Rev Microbiol 2003;1:1724.
3.Casadevall, A, Pirofski, LA.What is a host? Attributes of individual susceptibility. Infect Immun 2018;86:e0063617.
4.Casadevall, A, Pirofski, LA.Ditch the term pathogen. Nature 2014;516:165166.
5.Casadevall, A, Pirofski, LA.The damage–response framework of microbial pathogenesis. Nat Rev Microbiol 2003;1:1724.
6.Casadevall, A, Pirofski, LA.Benefits and costs of animal virulence for microbes. MBio 2019;10:e0086319.
7.Casadevall, A, Pirofski, LA.What is a host? Incorporating the microbiota into the damage-response framework. Infect Immun 2015;83:27.
8.Pirofski, LA, Casadevall, A.Immune-mediated damage completes the parabola: Cryptococcus neoformans pathogenesis can reflect the outcome of a weak or strong immune response. MBio 2017;8:e0206317.
9.HAI data and statistics. Centers for Disease Control and Prevention website. https://www.cdc.gov/hai/surveillance/. Published 2016. Accessed April 18, 2019.
10.Magill, SS, O’Leary, E, Janelle, SJ, et al.Changes in prevalence of healthcare-associated infections in US hospitals. N Engl J Med 2018;379:17321744.
11.Schreiber, PW, Sax, H, Wolfensberger, A, Clack, L, Kuster, SP.The preventable proportion of healthcare-associated infections 2005–2016: systematic review and meta-analysis. Infect Control Hosp Epidemiol 2018;39:12771295.
12.Roth, JA, Battegay, M, Juchler, F, Vogt, JE, Widmer, AF.Introduction to machine learning in digital healthcare epidemiology. Infect Control Hosp Epidemiol 2018;39:14571462.
13.Oh, J, Makar, M, Fusco, C, et al.A generalizable, data-driven approach to predict daily risk of Clostridium difficile infection at two large academic health centers. Infect Control Hosp Epidemiol 2018;39:425433.
14.Sanger, PC, van Ramshorst, GH, Mercan, E, et al.A prognostic model of surgical site infection using daily clinical wound assessment. J Am Coll Surg 2016;223:259270.e2.
15.Bartz-Kurycki, MA, Green, C, Anderson, KT, et al.Enhanced neonatal surgical site infection prediction model utilizing statistically and clinically significant variables in combination with a machine learning algorithm. Am J Surg 2018;216:764777.
16.Escobar, GJ, Baker, JM, Kipnis, P, et al.Prediction of recurrent Clostridium difficile infection using comprehensive electronic medical records in an integrated healthcare delivery system. Infect Control Hosp Epidemiol 2017;38:11961203.
17.Peiffer-Smadja, N, Rawson, TM, Ahmad, R, et al.Machine learning for clinical decision support in infectious diseases: a narrative review of current applications. Clin Microbiol Infect 2019; pii:S1198:30494-X.
18.Wenzel, RP.Surgical site infections and the microbiome: an updated perspective. Infect Control Hosp Epidemiol 2019;40:590596.
19.Bode, LGM, Kluytmans, JAJW, Wertheim, HFL, et al.Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010;362:917.
20.Climo, MW, Yokoe, DS, Warren, DK, et al.Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013;368:533542.
21.Huang, SS, Septimus, E, Kleinman, K, et al.Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013;368:22552265.
22.Van Rijen, M, Bonten, M, Wenzel, R, Kluytmans, J.Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev 2008:CD006216.
23.Thomas, C, Stevenson, M, Riley, T V.Antibiotics and hospital-acquired Clostridium difficile–associated diarrhoea: a systematic review. J Antimicrob Chemother 2003;51:13391350.
24.Loo, VG, Bourgault, AM, Poirier, L, et al.Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011;365:16931703.
25.Keith, JW, Pamer, EG.Enlisting commensal microbes to resist antibiotic-resistant pathogens. J Exp Med 2019;216:1019.
26.Relman, DA, Lipsitch, M.Microbiome as a tool and a target in the effort to address antimicrobial resistance. Proc Natl Acad Sci 2018;115:1290212910.
27.Kokai-Kun, JF, Roberts, T, Coughlin, O, et al.Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam–treated patients: a double-blind, phase 2b, randomised placebo-controlled trial. Lancet Infect Dis 2019;19:487496.
28.He, J, Li, Y, Zhang, H, et al.Immune function assay (ImmuKnow) as a predictor of allograft rejection and infection in kidney transplantation. Clin Transplant 2013;27:E351E358.
29.Seymour, CW, Kennedy, JN, Wang, S, et al.Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA 2019;321:20032017.
30.Kelly, CP, Chen, X, Williams, D, et al.Host immune markers distinguish clostridioides difficile infection from asymptomatic carriage and non–C. difficile diarrhea. Clin Infect Dis April 2019;pii:ciz330.
31.Drewry, AM, Fuller, BM, Bailey, TC, Hotchkiss, RS.Body temperature patterns as a predictor of hospital-acquired sepsis in afebrile adult intensive care unit patients: a case–control study. Crit Care 2013;17:R200.
32.Anderson, DJ, Podgorny, K, Berríos-Torres, SI, et al.Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014;35:605627.
33.Sessler, DI.Complications and treatment of mild hypothermia. Anesthesiology 2001;95:531543.
34.Melling, AC, Ali, B, Scott, EM, Leaper, DJ.Effects of preoperative warming on the incidence of wound infection after clean surgery: a randomised controlled trial. Lancet 2001;358:876880.
35.Duval, A, Obadia, T, Boëlle, PY, et al.Close proximity interactions support transmission of ESBL-K. pneumoniae but not ESBL-E. coli in healthcare settings. PLoS Comput Biol 2019;15:e1006496.
36.Katona, P, Katona-Apte, J. The interaction between nutrition and infection. Clin Infect Dis 2008;46:15821588.
37.Meijs, AP, Koek, MBG, Vos, MC, Geerlings, SE, Vogely, HC, De Greeff, SC.The effect of body mass index on the risk of surgical site infection. Infect Control Hosp Epidemiol 2019;40:991996.
38.Kerkhoffs, GMMJ, Servien, E, Dunn, W, Dahm, D, Bramer, JAM, Haverkamp, D.The influence of obesity on the complication rate and outcome of total knee arthroplasty. J Bone Jt Surg 2012;94:18391844.

The damage response framework and infection prevention: From concept to bedside

  • Emily J. Godbout (a1), Theresa Madaline (a2), Arturo Casadevall (a3), Gonzalo Bearman (a4) and Liise-anne Pirofski (a2)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.